These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson's Disease. Al-Nusaif M; Lin Y; Li T; Cheng C; Le W Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555826 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic Regulation of Neuroinflammation in Parkinson's Disease. Rasheed M; Liang J; Wang C; Deng Y; Chen Z Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066949 [TBL] [Abstract][Full Text] [Related]
4. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease. Campos-Acuña J; Elgueta D; Pacheco R Front Immunol; 2019; 10():239. PubMed ID: 30828335 [TBL] [Abstract][Full Text] [Related]
5. The role of Toll-like receptors and neuroinflammation in Parkinson's disease. Heidari A; Yazdanpanah N; Rezaei N J Neuroinflammation; 2022 Jun; 19(1):135. PubMed ID: 35668422 [TBL] [Abstract][Full Text] [Related]
7. The gut microbiome in Parkinson's disease: A culprit or a bystander? Keshavarzian A; Engen P; Bonvegna S; Cilia R Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371 [TBL] [Abstract][Full Text] [Related]
8. A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson's disease. Mani S; Sevanan M; Krishnamoorthy A; Sekar S Neurol Sci; 2021 Nov; 42(11):4459-4469. PubMed ID: 34480241 [TBL] [Abstract][Full Text] [Related]
9. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease. Cui C; Han Y; Li H; Yu H; Zhang B; Li G Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698 [TBL] [Abstract][Full Text] [Related]
10. Neuroinflammation in Parkinson's Disease: Triggers, Mechanisms, and Immunotherapies. Wang T; Shi C; Luo H; Zheng H; Fan L; Tang M; Su Y; Yang J; Mao C; Xu Y Neuroscientist; 2022 Aug; 28(4):364-381. PubMed ID: 33576313 [TBL] [Abstract][Full Text] [Related]
11. Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson's disease. Kip E; Parr-Brownlie LC Ageing Res Rev; 2022 Jun; 78():101618. PubMed ID: 35395416 [TBL] [Abstract][Full Text] [Related]
12. Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management. Sharma S; Awasthi A; Singh S Neurosci Lett; 2019 Nov; 712():134516. PubMed ID: 31560998 [TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease. Rocha EM; De Miranda B; Sanders LH Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134 [TBL] [Abstract][Full Text] [Related]
15. Evidence for immune system alterations in peripheral biological fluids in Parkinson's disease. Bartl M; Xylaki M; Bähr M; Weber S; Trenkwalder C; Mollenhauer B Neurobiol Dis; 2022 Aug; 170():105744. PubMed ID: 35513230 [TBL] [Abstract][Full Text] [Related]
16. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980 [TBL] [Abstract][Full Text] [Related]
17. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease. Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770 [TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota Interact With the Brain Through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging. Mou Y; Du Y; Zhou L; Yue J; Hu X; Liu Y; Chen S; Lin X; Zhang G; Xiao H; Dong B Front Immunol; 2022; 13():796288. PubMed ID: 35464431 [TBL] [Abstract][Full Text] [Related]
20. Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis. Chen SJ; Lin CH J Biomed Sci; 2022 Jul; 29(1):54. PubMed ID: 35897024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]